|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8200 AUD | -1.20% |
|
-8.89% | -24.42% |
| 10/03 | Orthocell Names UK Distributor For Nerve Repair Product, Shares Jump 3% | MT |
| 24/02 | Orthocell Limited Reports Earnings Results for the Half Year Ended December 31, 2025 | CI |
| Capitalization | 225M 161M 138M 125M 120M 218M 14.77B 1.47B 589M 7.08B 604M 591M 25.36B | P/E ratio 2026 * |
-
| P/E ratio 2027 * | - |
|---|---|---|---|---|---|
| Enterprise value | 181M 130M 111M 101M 96.33M 176M 11.9B 1.18B 474M 5.71B 486M 476M 20.44B | EV / Sales 2026 * |
13.1x | EV / Sales 2027 * | 7.85x |
| Free-Float |
75.86% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.20% | ||
| 1 week | -8.89% | ||
| Current month | -13.68% | ||
| 1 month | -16.33% | ||
| 3 months | -21.90% | ||
| 6 months | -26.13% | ||
| Current year | -24.42% |
| 1 week | 0.77 |  | 0.92 |
| 1 month | 0.77 | | 1 |
| Current year | 0.77 | | 1.16 |
| 1 year | 0.77 | | 1.7 |
| 3 years | 0.32 | | 1.79 |
| 5 years | 0.3 | | 1.79 |
| 10 years | 0.1 | | 1.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Hao Zheng
CTO | Chief Tech/Sci/R&D Officer | - | 21/03/2006 |
Paul Anderson
CEO | Chief Executive Officer | 60 | 21/03/2006 |
Tony Macintyre
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Anderson
BRD | Director/Board Member | 60 | 21/03/2006 |
Ravi Thadhani
BRD | Director/Board Member | 60 | 08/03/2023 |
| Chairman | - | 01/06/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.20% | -8.89% | -32.23% | +115.79% | 161M | |
| -1.94% | -1.58% | -5.07% | -8.04% | 186B | |
| -1.56% | -2.33% | +0.67% | +116.17% | 173B | |
| -1.80% | -4.31% | -4.88% | -18.57% | 138B | |
| -2.70% | -5.27% | -25.68% | +50.52% | 104B | |
| -1.35% | -4.95% | -23.66% | -19.57% | 51.95B | |
| +1.80% | +0.59% | +25.17% | +15.39% | 49.82B | |
| -2.30% | -4.32% | +4.43% | +20.04% | 35.84B | |
| -3.83% | -6.91% | -14.80% | -2.99% | 33.15B | |
| -1.04% | -3.03% | -5.31% | -14.95% | 32.62B | |
| Average | -1.60% | -3.52% | -8.14% | +25.38% | 80.37B | |
| Weighted average by Cap. | -1.72% | -2.87% | -5.79% | +26.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.9M 9.93M 8.52M 7.71M 7.38M 13.48M 912M 90.76M 36.34M 437M 37.26M 36.47M 1.57B | 24.1M 17.21M 14.78M 13.36M 12.79M 23.36M 1.58B 157M 63.01M 758M 64.6M 63.23M 2.71B |
| Net income | - | - |
| Net Debt | -43.7M -31.21M -26.8M -24.23M -23.2M -42.36M -2.87B -285M -114M -1.37B -117M -115M -4.92B | -36.1M -25.78M -22.14M -20.01M -19.16M -35M -2.37B -236M -94.38M -1.14B -96.76M -94.71M -4.06B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/03/26 | 0.8200 $ | -1.20% | 212,293 |
| 10/03/26 | 0.8300 $ | +3.75% | 343,481 |
| 09/03/26 | 0.8000 $ | -9.60% | 1,365,990 |
| 06/03/26 | 0.8850 $ | -1.12% | 346,239 |
| 05/03/26 | 0.8950 $ | -0.56% | 120,828 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8300AUD
Average target price
1.330AUD
Spread / Average Target
+60.24%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OCC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition